Plasmocitoma extramidollare (P.E.M.) della testa e del collo: considerazioni su 22 casi.

Translated title of the contribution: Extramedullary plasmocytoma (EMP) of the head and neck: a series of 22 cases

F. Tesei, U. Caliceti, G. Sorrenti, A. Canciullo, E. Sabbatini, S. Pileri, S. Neri, G. Frezza, A. Rinaldi Ceroni

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Plasmacytoma is a rare neoplastic disorder arising from B-cell series lymphocytes. It can develop in three clinical variants: a) Multiple Myeloma (M.M.); b) Solitary Plasmacytoma of the bone; c) Extramedullary Plasmacytoma (EMP). EMP generally occurs in the submucosal tissue of the upper airways (80% of cases). This paper reports 22 cases of EMP of the head and neck observed in the last 20 years and reviews pertinent Literature. Four of our cases were located in the nasopharynx, four in the oropharynx and five in naso-sinusal sites. More rarely, the lesion occurred in the larynx (2 cases) or in the oral cavity (3 cases). In 4 patients multiple localizations in the upper airways were observed. Full evaluation was carried out in order to exclude disseminated disease. With the exception of 2 cases which were surgically treated, radiotherapy (RT) represented the treatment of choice in all patients, with doses ranging from 36 to 58 Gy. In 9 cases RT was administered after complete surgical resection. Follow-up time ranged from 13 to 167 months (mean 69.6). A partial response after treatment was observed in 4 cases. In only two of these cases neoplastic residue was observed (further RT allowed complete remission of the disease). In the other two cases, residual masses consisted in amyloid deposits. Three patients developed disseminated disease (MM) after a disease-free period ranging from 3 to 6 years. Five-year actuarial disease was 92%. Although surgery is generally considered a diagnostic tool, in our opinion local disease should always be removed surgically when surgery produces low morbidity. Surgical debulking of the lesion can increase the probability or local radiotherapeutic control.

Original languageItalian
Pages (from-to)437-442
Number of pages6
JournalActa Otorhinolaryngologica Italica
Volume15
Issue number6
Publication statusPublished - Dec 1995

Fingerprint

Plasmacytoma
Neck
Head
Radiotherapy
Oropharynx
Nasopharynx
Amyloid Plaques
Larynx
Multiple Myeloma
Mouth
B-Lymphocytes
Lymphocytes
Morbidity
Bone and Bones
Therapeutics

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Tesei, F., Caliceti, U., Sorrenti, G., Canciullo, A., Sabbatini, E., Pileri, S., ... Rinaldi Ceroni, A. (1995). Plasmocitoma extramidollare (P.E.M.) della testa e del collo: considerazioni su 22 casi. Acta Otorhinolaryngologica Italica, 15(6), 437-442.

Plasmocitoma extramidollare (P.E.M.) della testa e del collo : considerazioni su 22 casi. / Tesei, F.; Caliceti, U.; Sorrenti, G.; Canciullo, A.; Sabbatini, E.; Pileri, S.; Neri, S.; Frezza, G.; Rinaldi Ceroni, A.

In: Acta Otorhinolaryngologica Italica, Vol. 15, No. 6, 12.1995, p. 437-442.

Research output: Contribution to journalArticle

Tesei, F, Caliceti, U, Sorrenti, G, Canciullo, A, Sabbatini, E, Pileri, S, Neri, S, Frezza, G & Rinaldi Ceroni, A 1995, 'Plasmocitoma extramidollare (P.E.M.) della testa e del collo: considerazioni su 22 casi.', Acta Otorhinolaryngologica Italica, vol. 15, no. 6, pp. 437-442.
Tesei F, Caliceti U, Sorrenti G, Canciullo A, Sabbatini E, Pileri S et al. Plasmocitoma extramidollare (P.E.M.) della testa e del collo: considerazioni su 22 casi. Acta Otorhinolaryngologica Italica. 1995 Dec;15(6):437-442.
Tesei, F. ; Caliceti, U. ; Sorrenti, G. ; Canciullo, A. ; Sabbatini, E. ; Pileri, S. ; Neri, S. ; Frezza, G. ; Rinaldi Ceroni, A. / Plasmocitoma extramidollare (P.E.M.) della testa e del collo : considerazioni su 22 casi. In: Acta Otorhinolaryngologica Italica. 1995 ; Vol. 15, No. 6. pp. 437-442.
@article{0a7f87d887004770b68b423af9f4244b,
title = "Plasmocitoma extramidollare (P.E.M.) della testa e del collo: considerazioni su 22 casi.",
abstract = "Plasmacytoma is a rare neoplastic disorder arising from B-cell series lymphocytes. It can develop in three clinical variants: a) Multiple Myeloma (M.M.); b) Solitary Plasmacytoma of the bone; c) Extramedullary Plasmacytoma (EMP). EMP generally occurs in the submucosal tissue of the upper airways (80{\%} of cases). This paper reports 22 cases of EMP of the head and neck observed in the last 20 years and reviews pertinent Literature. Four of our cases were located in the nasopharynx, four in the oropharynx and five in naso-sinusal sites. More rarely, the lesion occurred in the larynx (2 cases) or in the oral cavity (3 cases). In 4 patients multiple localizations in the upper airways were observed. Full evaluation was carried out in order to exclude disseminated disease. With the exception of 2 cases which were surgically treated, radiotherapy (RT) represented the treatment of choice in all patients, with doses ranging from 36 to 58 Gy. In 9 cases RT was administered after complete surgical resection. Follow-up time ranged from 13 to 167 months (mean 69.6). A partial response after treatment was observed in 4 cases. In only two of these cases neoplastic residue was observed (further RT allowed complete remission of the disease). In the other two cases, residual masses consisted in amyloid deposits. Three patients developed disseminated disease (MM) after a disease-free period ranging from 3 to 6 years. Five-year actuarial disease was 92{\%}. Although surgery is generally considered a diagnostic tool, in our opinion local disease should always be removed surgically when surgery produces low morbidity. Surgical debulking of the lesion can increase the probability or local radiotherapeutic control.",
author = "F. Tesei and U. Caliceti and G. Sorrenti and A. Canciullo and E. Sabbatini and S. Pileri and S. Neri and G. Frezza and {Rinaldi Ceroni}, A.",
year = "1995",
month = "12",
language = "Italian",
volume = "15",
pages = "437--442",
journal = "Acta Otorhinolaryngologica Italica",
issn = "0392-100X",
publisher = "Pacini Editore s.r.l.",
number = "6",

}

TY - JOUR

T1 - Plasmocitoma extramidollare (P.E.M.) della testa e del collo

T2 - considerazioni su 22 casi.

AU - Tesei, F.

AU - Caliceti, U.

AU - Sorrenti, G.

AU - Canciullo, A.

AU - Sabbatini, E.

AU - Pileri, S.

AU - Neri, S.

AU - Frezza, G.

AU - Rinaldi Ceroni, A.

PY - 1995/12

Y1 - 1995/12

N2 - Plasmacytoma is a rare neoplastic disorder arising from B-cell series lymphocytes. It can develop in three clinical variants: a) Multiple Myeloma (M.M.); b) Solitary Plasmacytoma of the bone; c) Extramedullary Plasmacytoma (EMP). EMP generally occurs in the submucosal tissue of the upper airways (80% of cases). This paper reports 22 cases of EMP of the head and neck observed in the last 20 years and reviews pertinent Literature. Four of our cases were located in the nasopharynx, four in the oropharynx and five in naso-sinusal sites. More rarely, the lesion occurred in the larynx (2 cases) or in the oral cavity (3 cases). In 4 patients multiple localizations in the upper airways were observed. Full evaluation was carried out in order to exclude disseminated disease. With the exception of 2 cases which were surgically treated, radiotherapy (RT) represented the treatment of choice in all patients, with doses ranging from 36 to 58 Gy. In 9 cases RT was administered after complete surgical resection. Follow-up time ranged from 13 to 167 months (mean 69.6). A partial response after treatment was observed in 4 cases. In only two of these cases neoplastic residue was observed (further RT allowed complete remission of the disease). In the other two cases, residual masses consisted in amyloid deposits. Three patients developed disseminated disease (MM) after a disease-free period ranging from 3 to 6 years. Five-year actuarial disease was 92%. Although surgery is generally considered a diagnostic tool, in our opinion local disease should always be removed surgically when surgery produces low morbidity. Surgical debulking of the lesion can increase the probability or local radiotherapeutic control.

AB - Plasmacytoma is a rare neoplastic disorder arising from B-cell series lymphocytes. It can develop in three clinical variants: a) Multiple Myeloma (M.M.); b) Solitary Plasmacytoma of the bone; c) Extramedullary Plasmacytoma (EMP). EMP generally occurs in the submucosal tissue of the upper airways (80% of cases). This paper reports 22 cases of EMP of the head and neck observed in the last 20 years and reviews pertinent Literature. Four of our cases were located in the nasopharynx, four in the oropharynx and five in naso-sinusal sites. More rarely, the lesion occurred in the larynx (2 cases) or in the oral cavity (3 cases). In 4 patients multiple localizations in the upper airways were observed. Full evaluation was carried out in order to exclude disseminated disease. With the exception of 2 cases which were surgically treated, radiotherapy (RT) represented the treatment of choice in all patients, with doses ranging from 36 to 58 Gy. In 9 cases RT was administered after complete surgical resection. Follow-up time ranged from 13 to 167 months (mean 69.6). A partial response after treatment was observed in 4 cases. In only two of these cases neoplastic residue was observed (further RT allowed complete remission of the disease). In the other two cases, residual masses consisted in amyloid deposits. Three patients developed disseminated disease (MM) after a disease-free period ranging from 3 to 6 years. Five-year actuarial disease was 92%. Although surgery is generally considered a diagnostic tool, in our opinion local disease should always be removed surgically when surgery produces low morbidity. Surgical debulking of the lesion can increase the probability or local radiotherapeutic control.

UR - http://www.scopus.com/inward/record.url?scp=0029456304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029456304&partnerID=8YFLogxK

M3 - Articolo

C2 - 8711997

AN - SCOPUS:0029456304

VL - 15

SP - 437

EP - 442

JO - Acta Otorhinolaryngologica Italica

JF - Acta Otorhinolaryngologica Italica

SN - 0392-100X

IS - 6

ER -